NCT07579845

Brief Summary

The primary purpose of this study is to evaluate the impact of BioToxin Binder, a commercially available dietary supplement containing humic and fulvic acid, on markers of biologic age, detoxification, inflammation, oxidative stress, and related markers among generally healthy adults.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
3mo left

Started May 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress18%
May 2026Sep 2026

First Submitted

Initial submission to the registry

April 30, 2026

Completed
1 day until next milestone

Study Start

First participant enrolled

May 1, 2026

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 12, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Last Updated

May 12, 2026

Status Verified

May 1, 2026

Enrollment Period

4 months

First QC Date

April 30, 2026

Last Update Submit

May 6, 2026

Conditions

DetoxificationInflammationBiological Aging

Outcome Measures

Primary Outcomes (1)

  • TruDiagnostic - Epigenetic Testing

    TruAge Test

    Change in TruAge from baseline to 12 weeks

Study Arms (1)

Humic and Fulvic Acid Dietary Supplement

EXPERIMENTAL
Dietary Supplement: Humic and Fulvic Acid Dietary Supplement

Interventions

Humic and Fulvic Acid Dietary SupplementDIETARY_SUPPLEMENT

BioToxin Binder - Humic and Fulvic Acid Dietary Supplement

Humic and Fulvic Acid Dietary Supplement

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult females or males age ≥ 40 years
  • Ability to read and speak English

You may not qualify if:

  • Current use of a dietary supplement containing fulvic or humic acid
  • Current use of other binder dietary supplements, including activated charcoal, modified citrus pectin, bentonite clay, or chlorella
  • Known allergies to any ingredients in the product
  • Currently pregnant or lactating women or women planning to become pregnant in the next 12 weeks
  • Current diagnosis of a chronic health condition (e.g., cancer, heart failure, history of pancreatitis, type I or II diabetics on insulin) deemed clinically contraindicated for the study protocol
  • Participants unable to provide consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

OvationLab

Richmond, Virginia, 23220, United States

Location

MeSH Terms

Conditions

Inflammation

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Administrator

CONTACT

(240) 232-2103info@ovationlab.com

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 30, 2026

First Posted

May 12, 2026

Study Start

May 1, 2026

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

May 12, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations

US(1)